Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytoreductive surgery with perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei (PMP study)
jRCTs031180254Completed
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mitomycin c and fluorouracil in pseudomyxoma peritonei (PMP). Primary endpoint: Overall survival at 5 years. Started Nov 2014; status: completed.
02
Drugs
mitomycin cfluorouracil
03
Conditions
pseudomyxoma peritonei (PMP)
Beyond the preview
Go deeper on jRCTs031180254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180254.